Epidemiologie, Prävention und Früherkennung des Zervixkarzinoms

详细信息    查看全文

• 作者：PD Dr. med. Nicolas Wentzensen
• 关键词：SchlüsselwörterZervixkarzinom ; Humane Papillomaviren ; Screening ; Biomarker ; Risikobasiertes Management
• 刊名：Der Onkologe
• 出版年：2016
• 出版时间：October 2016
• 年：2016
• 卷：22
• 期：10
• 页码：725-736
• 全文大小：667 KB
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-0415
• 卷排序：22

文摘

BackgroundPersisting infections with human papillomaviruses (HPV) are the indisputable cause of cervical cancer. The development of HPV-based preventive procedures, HPV vaccination and HPV testing are currently leading to major changes in cervical cancer prevention programs worldwide. A reduction of HPV infections and cancer precursors has been observed for young women in many countries one decade after the introduction of HPV vaccination. The focus is now on the integration of new testing approaches for screening of populations with increasing vaccination rates.